These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 19406036

  • 21. In vitro generation of three-dimensional substrate-adherent embryonic stem cell-derived neural aggregates for application in animal models of neurological disorders.
    Hargus G, Cui YF, Dihné M, Bernreuther C, Schachner M.
    Curr Protoc Stem Cell Biol; 2012 May; Chapter 2():Unit 2D.11. PubMed ID: 22605646
    [Abstract] [Full Text] [Related]

  • 22. Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats.
    Rumpel R, Alam M, Klein A, Özer M, Wesemann M, Jin X, Krauss JK, Schwabe K, Ratzka A, Grothe C.
    Neurobiol Dis; 2013 Nov; 59():230-43. PubMed ID: 23938762
    [Abstract] [Full Text] [Related]

  • 23. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
    Iancu R, Mohapel P, Brundin P, Paul G.
    Behav Brain Res; 2005 Jul 01; 162(1):1-10. PubMed ID: 15922062
    [Abstract] [Full Text] [Related]

  • 24. Survival and engraftment of dopaminergic neurons manufactured by a Good Manufacturing Practice-compatible process.
    Peng J, Liu Q, Rao MS, Zeng X.
    Cytotherapy; 2014 Sep 01; 16(9):1305-12. PubMed ID: 25065637
    [Abstract] [Full Text] [Related]

  • 25. BDNF receptor blockade hinders the beneficial effects of exercise in a rat model of Parkinson's disease.
    Real CC, Ferreira AF, Chaves-Kirsten GP, Torrão AS, Pires RS, Britto LR.
    Neuroscience; 2013 May 01; 237():118-29. PubMed ID: 23396085
    [Abstract] [Full Text] [Related]

  • 26. Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
    Muramatsu S, Okuno T, Suzuki Y, Nakayama T, Kakiuchi T, Takino N, Iida A, Ono F, Terao K, Inoue N, Nakano I, Kondo Y, Tsukada H.
    Synapse; 2009 Jul 01; 63(7):541-8. PubMed ID: 19253400
    [Abstract] [Full Text] [Related]

  • 27. Human induced pluripotent stem cell-derived neurons improve motor asymmetry in a 6-hydroxydopamine-induced rat model of Parkinson's disease.
    Han F, Wang W, Chen B, Chen C, Li S, Lu X, Duan J, Zhang Y, Zhang YA, Guo W, Li G.
    Cytotherapy; 2015 May 01; 17(5):665-79. PubMed ID: 25747741
    [Abstract] [Full Text] [Related]

  • 28. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
    Gu S, Huang H, Bi J, Yao Y, Wen T.
    Brain Res; 2009 Feb 27; 1257():1-9. PubMed ID: 19111525
    [Abstract] [Full Text] [Related]

  • 29. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF, Hargus G, Xu JC, Schmid JS, Shen YQ, Glatzel M, Schachner M, Bernreuther C.
    Brain; 2010 Jan 27; 133(Pt 1):189-204. PubMed ID: 19995872
    [Abstract] [Full Text] [Related]

  • 30. The colayer method as an efficient way to genetically modify mesencephalic progenitor cells transplanted into 6-OHDA rat model of Parkinson's disease.
    Ratzka A, Kalve I, Özer M, Nobre A, Wesemann M, Jungnickel J, Köster-Patzlaff C, Baron O, Grothe C.
    Cell Transplant; 2012 Jan 27; 21(4):749-62. PubMed ID: 21929871
    [Abstract] [Full Text] [Related]

  • 31. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
    Heim RC, Willingham G, Freed WJ.
    Exp Neurol; 1993 Jul 27; 122(1):5-15. PubMed ID: 8101821
    [Abstract] [Full Text] [Related]

  • 32. Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats.
    Veng LM, Bjugstad KB, Freed CR, Marrack P, Clarkson ED, Bell KP, Hutt C, Zawada WM.
    Cell Transplant; 2002 Jul 27; 11(1):5-16. PubMed ID: 12095220
    [Abstract] [Full Text] [Related]

  • 33. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D, Henze C, Strenzke C, Westrich J, Ferger B, Höglinger GU, Oertel WH, Hartmann A.
    Exp Neurol; 2008 Mar 27; 210(1):182-93. PubMed ID: 18053987
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Neural-tube-derived neuroepithelial stem cells: a new transplant resource for Parkinson's disease.
    Sun J, Gao Y, Yang L, Li Z, Lu G, Yew D.
    Neuroreport; 2007 Apr 16; 18(6):543-7. PubMed ID: 17413654
    [Abstract] [Full Text] [Related]

  • 37. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
    Höglinger GU, Widmer HR, Spenger C, Meyer M, Seiler RW, Oertel WH, Sautter J.
    Exp Neurol; 2001 Jan 16; 167(1):148-57. PubMed ID: 11161602
    [Abstract] [Full Text] [Related]

  • 38. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
    Baker KA, Hong M, Sadi D, Mendez I.
    Exp Neurol; 2000 Apr 16; 162(2):350-60. PubMed ID: 10739641
    [Abstract] [Full Text] [Related]

  • 39. Protective and restorative effects of magnolol on neurotoxicity in mice with 6-hydroxydopamine-induced hemiparkinsonism.
    Chen HH, Lin SC, Chan MH.
    Neurodegener Dis; 2011 Apr 16; 8(5):364-74. PubMed ID: 21494012
    [Abstract] [Full Text] [Related]

  • 40. NanoCsA improves the survival of human iPSC transplant in hemiparkinsonian rats.
    Yu SJ, Wang YC, Chang CY, Hsieh W, Chen S, Yang CS, Lin SZ, Wang Y.
    Brain Res; 2019 Sep 15; 1719():124-132. PubMed ID: 31153914
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.